1HUNOT S,HIRSCH E C. Neuroinflammatory processes in Parkinson's disease[J ] . Ann Neuro,2003,53(3) :49-60.
2ZLONKOWSKA A,KURKOWSKA J I,CZLONKOWSKI,et al. Immune processes in the pathogenesis of Parkinson's disease 2a potential role for microglia and nitric oxide[J ].Med Sci Monit,2002,8(8):165-177.
3KIM W G,MOHNEY R P,WILSON B, et al.Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain:role of microglia[J]. J Neurosci, 2000,20(16):6309-6316.
4LE W,ROWE D,XIE W,et al. Microglial activation and dopaminergic cell injury: an in vitro model relevantto Parkinson's disease[J]. J Neurosci, 2001,21(21):8447-8455.
5NATHANSON J A,SCANONE C,SCANLON C,et al. The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechansim for long-term modulation of cellular activiting[J]. Neuron,1995,14(4):781-794.
6WU D C,JACKSON-LEWIS V,VILA M,et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4 phenyl -1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease[J]. Proc J Neurosci,2002,22(5):1763-1771.
7LIU B,DU L,HONG J S. Naloxone protects rat dopaminergic neurons against inflammatory damageth rough inhibition of microgliaactivation and superoxide generation[J]. J Pharmacoil Exp Ther,2000,293(2):607-617.
8HERRERA A J,CASTANO A,VENERO J L,et al. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system [J]. Neurobio Dis,2000,7(4):429-447.
9LIU B,JIANG J W,WILSON B C,et al. Systernic infusion of Naloxone reduces degeneration of rat subtantial nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide [J]. J Pharmacol Exp Ther,2000,295(1):125-132.
10PFEFFERBORN T,STAUFER B,LIEBETRAU M,et al. Plasminogen activation in focal cerebral ischemia and reperfusion[J]. J Cereb Blood Flow Metab,2000,20(2):337-342.
2Aubin N,Curet O,Deffois A,et al.Aspirin and salicylate protect against MPTP induced dopamine depletion in mice[J]. J Neurochem,1998,71:1635-1642.
3Matsuura K,Kabuto H,Makino H,et al. Cyclosporin A attenuates degeneration of dopaminergic neuron induced by 6-hydroxydopamine in the mouse brain[J].Brain Res,1996,733:101-104.
4Kuhn W,Muller T,Nastos I,et al. The neuroimmune hypothesis in Parkinson's disease[J].Rev Neurosci,1997,8:29-34.
5Bjorklund A,Rosenblad C,Winkler C.et al .Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease[J]. Neurobiol Dis,1997,4:186-200.
6Hunot S,Betard C,Faucheux B,et al.Immunohistochemical analysis of interferon-γ and interlekuin-1 in the substantia nigra of Parkinson's disease[J].Mov Disord, 1997,12(Suppl):20.
7Hirsch EC,Hunot S,Damier P,et al.Glial cells and inflammation in Parkinson's disease:A role in neurodegeneration[J]. Ann Neurol, 1998,44(Suppl):S115-120.
8Mogi M,Harada M,Kondo T,et al . Interlekuin-1, interlekuin-6,epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients[J].Ann Neruol, 1994,180:147-150.
9Mogi M,Harada M,Riedeereer P,et al .Tumor necrosis factor-alpha increases both in the brain and in the cerebrospinal fluid from parkinsonian patients[J].Neurosci Lett,1994,165:208-210.
10StreitWJ,WalterSA,PennellNA.Reactive microgliosis[].Progress in Neurobiology.1999
